ifosfamide has been researched along with Proteinuria in 22 studies
Proteinuria: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ifosfamide and cisplatin are active agents that are currently used in the treatment of osteosarcoma." | 7.70 | Renal function following combination chemotherapy with ifosfamide and cisplatin in patients with osteogenic sarcoma. ( Arndt, C; Hawkins, D; Liedtke, R; Miser, J; Morgenstern, B; Wilson, D, 1999) |
| " Nephrotoxicity is a known side effect of several treatments, including cisplatin, carboplatin, ifosfamide, radiotherapy and nephrectomy, and can cause glomerular filtration rate (GFR) impairment, proteinuria, tubulopathy, and hypertension." | 5.01 | Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer. ( Bökenkamp, A; Kooijmans, EC; Tettero, JM; Tjahjadi, NS; van der Pal, HJ; van Dulmen-den Broeder, E; Veening, MA, 2019) |
| " Nephrotoxicity is one of these known (acute) side effects of several treatments, including cisplatin, carboplatin, ifosfamide, radiotherapy and nephrectomy, and can cause glomerular filtration rate impairment, proteinuria, tubulopathy and hypertension." | 4.89 | Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer. ( Blufpand, H; Bökenkamp, A; Jaspers, MW; Knijnenburg, SL; Kremer, LC; Mulder, RL; Schouten-Van Meeteren, AY; van Dulmen-den Broeder, E; Veening, MA, 2013) |
| "To evaluate proteinuria occurring early after ifosfamide therapy and to assess the use of changes in proteinuria in the prediction of severe chronic nephrotoxicity." | 3.70 | Acute changes in urine protein excretion may predict chronic ifosfamide nephrotoxicity: a preliminary observation. ( English, M; Hall, AG; MacLean, FR; Pearson, AD; Skinner, R, 1998) |
| "Ifosfamide and cisplatin are active agents that are currently used in the treatment of osteosarcoma." | 3.70 | Renal function following combination chemotherapy with ifosfamide and cisplatin in patients with osteogenic sarcoma. ( Arndt, C; Hawkins, D; Liedtke, R; Miser, J; Morgenstern, B; Wilson, D, 1999) |
| "In addition, polyploidy of TEC was observed to correlate with loss of lysozyme staining." | 1.91 | Cellular senescence in kidney biopsies is associated with tubular dysfunction and predicts CKD progression in childhood cancer patients with karyomegalic interstitial nephropathy. ( Broekhuizen, R; Goldschmeding, R; Haveman, LM; Janssens, GO; Keijzer-Veen, MG; Knoppert, SN; Lilien, MR; Nguyen, TQ; Stokman, MF; Valentijn, FA; van den Berg, G; van den Heuvel-Eibrink, MM; van Kempen, S, 2023) |
| "The renal Fanconi syndrome is a defect of proximal tubular function causing aminoaciduria and low-molecular-weight proteinuria." | 1.34 | Combined proteomic and metabonomic studies in three genetic forms of the renal Fanconi syndrome. ( Capasso, G; Cutillas, PR; Holmes, E; Maher, AD; Nicholson, JK; Norden, AW; Unwin, RJ; Vilasi, A; Zirah, SF, 2007) |
| "The patients with prostatic cancer were treated with VIP (vincristine, ifosfamide, peplomycin) chemotherapy and the patients with urothelial cancer were treated with MP (methotrexate, cisplatinum) or MEP (methotrexate, Etoposide, cisplatinum) combination chemotherapy." | 1.29 | [Comparative study on urinary parameters reflecting renal damage during chemotherapy for urological cancer]. ( Kitamura, Y; Komatsubara, S; Sakata, Y; Watanabe, M, 1993) |
| " We observed this acute toxic effect despite the administration of sufficient mesna to prevent hemorrhagic cystitis." | 1.27 | Ifosfamide-induced subclinical tubular nephrotoxicity despite mesna. ( Goren, MP; Horowitz, ME; Pratt, CB; Wright, RK, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (22.73) | 18.7374 |
| 1990's | 8 (36.36) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 5 (22.73) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Knoppert, SN | 1 |
| Keijzer-Veen, MG | 1 |
| Valentijn, FA | 1 |
| van den Heuvel-Eibrink, MM | 1 |
| Lilien, MR | 1 |
| van den Berg, G | 1 |
| Haveman, LM | 1 |
| Stokman, MF | 1 |
| Janssens, GO | 1 |
| van Kempen, S | 1 |
| Broekhuizen, R | 1 |
| Goldschmeding, R | 1 |
| Nguyen, TQ | 1 |
| Kooijmans, EC | 1 |
| Bökenkamp, A | 2 |
| Tjahjadi, NS | 1 |
| Tettero, JM | 1 |
| van Dulmen-den Broeder, E | 2 |
| van der Pal, HJ | 1 |
| Veening, MA | 2 |
| Knijnenburg, SL | 1 |
| Mulder, RL | 1 |
| Schouten-Van Meeteren, AY | 1 |
| Blufpand, H | 1 |
| Kremer, LC | 1 |
| Jaspers, MW | 1 |
| Ramirez, MD | 1 |
| Mertens, AC | 1 |
| Esiashvili, N | 1 |
| Meacham, LR | 1 |
| Wasilewski-Masker, K | 1 |
| Yılmaz, S | 1 |
| Özçakar, ZB | 1 |
| Taktak, A | 1 |
| Kiremitçi, S | 1 |
| Ensari, A | 1 |
| Dinçaslan, H | 1 |
| Yalçınkaya, F | 1 |
| Vello Román, A | 1 |
| Samprón Rodríguez, M | 1 |
| Pazos Arias, B | 1 |
| Romero Reinoso, C | 1 |
| Peteiro Cancelo, A | 1 |
| Stöhr, W | 1 |
| Paulides, M | 1 |
| Bielack, S | 1 |
| Jürgens, H | 1 |
| Treuner, J | 1 |
| Rossi, R | 2 |
| Langer, T | 1 |
| Beck, JD | 1 |
| Hozhenko, AI | 1 |
| Trusova, MV | 1 |
| Vilasi, A | 1 |
| Cutillas, PR | 1 |
| Maher, AD | 1 |
| Zirah, SF | 1 |
| Capasso, G | 1 |
| Norden, AW | 1 |
| Holmes, E | 1 |
| Nicholson, JK | 1 |
| Unwin, RJ | 1 |
| Hacke, M | 1 |
| Schmoll, HJ | 1 |
| Alt, JM | 1 |
| Baumann, K | 1 |
| Stolte, H | 1 |
| Kitamura, Y | 1 |
| Watanabe, M | 1 |
| Komatsubara, S | 1 |
| Sakata, Y | 1 |
| Rossi, RM | 1 |
| Kist, C | 1 |
| Wurster, U | 1 |
| Külpmann, WR | 1 |
| Ehrich, JH | 2 |
| Rath, B | 1 |
| Ullrich, K | 1 |
| Tokuc, G | 1 |
| Yalçiner, A | 1 |
| Kebudi, R | 1 |
| Dogan, S | 1 |
| Görgün, O | 1 |
| Ayan, I | 1 |
| MacLean, FR | 1 |
| Skinner, R | 2 |
| Hall, AG | 1 |
| English, M | 1 |
| Pearson, AD | 2 |
| Arndt, C | 1 |
| Morgenstern, B | 1 |
| Hawkins, D | 1 |
| Wilson, D | 1 |
| Liedtke, R | 1 |
| Miser, J | 1 |
| Gysler, J | 1 |
| Schunack, W | 1 |
| Jaehde, U | 1 |
| Price, L | 1 |
| Coulthard, MG | 1 |
| Craft, AW | 1 |
| Goren, MP | 3 |
| Pratt, CB | 3 |
| Meyer, WH | 1 |
| Wright, RK | 2 |
| Dodge, RK | 1 |
| Viar, MJ | 2 |
| Horowitz, ME | 1 |
| Patterson, WP | 1 |
| Khojasteh, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Oral Supplementation With Magnesium to Reduce Febrile Neutropenia in Pediatric Oncology Patients Treated With Cisplatin-Based Chemotherapy: Randomized Clinical Trial[NCT03449693] | Phase 2 | 214 participants (Anticipated) | Interventional | 2017-10-19 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for ifosfamide and Proteinuria
| Article | Year |
|---|---|
Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.
Topics: Adult; Antineoplastic Agents; Carboplatin; Child; Cisplatin; Glomerular Filtration Rate; Humans; Hyp | 2019 |
Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.
Topics: Adult; Antineoplastic Agents; Carboplatin; Child; Cisplatin; Glomerular Filtration Rate; Humans; Hyp | 2013 |
2 trials available for ifosfamide and Proteinuria
| Article | Year |
|---|---|
Yield of Urinalysis Screening in Pediatric Cancer Survivors.
Topics: Adolescent; Adult; Child; Child, Preschool; Databases, Factual; Female; Follow-Up Studies; Glycosuri | 2016 |
[Ifosfamide-induced nephrotoxicity].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Cisplatin; Creatinine | 1993 |
18 other studies available for ifosfamide and Proteinuria
| Article | Year |
|---|---|
Cellular senescence in kidney biopsies is associated with tubular dysfunction and predicts CKD progression in childhood cancer patients with karyomegalic interstitial nephropathy.
Topics: Biopsy; Cellular Senescence; Child; Humans; Ifosfamide; In Situ Hybridization, Fluorescence; Kidney; | 2023 |
Anti-VEGF-related thrombotic microangiopathy in a child presenting with nephrotic syndrome.
Topics: Adolescent; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Pro | 2016 |
[Nephropathy following administration of angiogenesis inhibitors].
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineopl | 2011 |
Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System.
Topics: Abdomen; Adolescent; Age Factors; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemoth | 2007 |
[Effect of cytostatic ifosfamide on the function of the kidneys in white rats].
Topics: Animals; Antineoplastic Agents, Alkylating; Creatinine; Diuresis; Glycosuria; Ifosfamide; Kidney; Ma | 2006 |
Combined proteomic and metabonomic studies in three genetic forms of the renal Fanconi syndrome.
Topics: Adult; Antineoplastic Agents, Alkylating; Chloride Channels; DNA Fingerprinting; Fanconi Syndrome; F | 2007 |
Nephrotoxicity of cis-diamminedichloroplatinum with or without ifosfamide in cancer treatment.
Topics: Albuminuria; alpha-Glucosidases; beta 2-Microglobulin; Cisplatin; Cyclophosphamide; Drug Interaction | 1983 |
[Comparative study on urinary parameters reflecting renal damage during chemotherapy for urological cancer].
Topics: Acetylglucosaminidase; Adolescent; Adult; Aged; Aminopeptidases; Antineoplastic Combined Chemotherap | 1993 |
Estimation of ifosfamide/cisplatinum-induced renal toxicity by urinary protein analysis.
Topics: Adolescent; Adult; Child; Child, Preschool; Cisplatin; Drug Therapy, Combination; Electrophoresis, P | 1994 |
Renal dysfunctions secondary to ifosfamide treatment in children.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Child; Child, Preschool; Dose-Response Relationship, | 1997 |
Acute changes in urine protein excretion may predict chronic ifosfamide nephrotoxicity: a preliminary observation.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Child; Child, Preschool; Chronic Disease; Female; Hum | 1998 |
Renal function following combination chemotherapy with ifosfamide and cisplatin in patients with osteogenic sarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; | 1999 |
Monitoring of chemotherapy-induced proteinuria using capillary zone electrophoresis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Buffers; Calibration; Carboplatin; Electropho | 1999 |
Nephrotoxicity after ifosfamide.
Topics: Adolescent; Albuminuria; Bone and Bones; Child; Child, Preschool; Cross-Sectional Studies; Female; G | 1990 |
Mesna excretion and ifosfamide nephrotoxicity in children.
Topics: Adolescent; Adult; Child; Child, Preschool; Creatinine; Female; Humans; Ifosfamide; Kidney Diseases; | 1989 |
Tubular nephrotoxicity during long-term ifosfamide and mesna therapy.
Topics: Acetylglucosaminidase; Aminopeptidases; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; | 1989 |
Ifosfamide-induced subclinical tubular nephrotoxicity despite mesna.
Topics: Acetylglucosaminidase; Adolescent; Adult; Aminopeptidases; CD13 Antigens; Child; Child, Preschool; C | 1987 |
Ifosfamide-induced renal tubular defects.
Topics: Hematuria; Humans; Hydrogen-Ion Concentration; Ifosfamide; Kidney Diseases; Kidney Tubules; Lymphoma | 1989 |